Potential mechanisms for mortality reduction associated with combination antibiotic therapy among severely ill patients with pneumococcal bacteremia.
Schwartz
David N
DN
D000900:Anti-Bacterial Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016470:Bacteremia / Q000097:blood / Q000188:drug therapy / Q000401:mortality*; D003422:Critical Care / Q000379:methods; D016638:Critical Illness; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D011008:Pneumococcal Infections / Q000097:blood / Q000188:drug therapy / Q000401:mortality*; D012189:Retrospective Studies; D015996:Survival Rate / Q000639:trends; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents